| 产品描述: | I-BET787 is a orally active BET bromine domain inhibitor with pIC50s of 7.1 and 5.9 for BRD4 BD1 and BRD4 BD2, respectively. I-BET787 has anti-inflammatory activity in mice. |
| 靶点: |
BRD4 BD1:7.1 (pIC50); BRD4 BD2:5.9 (pIC50) |
| 体外研究: |
I-BET787 (1.5-15 mg/kg;口服;每日一次 (QD) 或每日两次 (BID),疗程 14 天) 在小鼠炎症模型中显示出有效性[1]。 |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.108 ml |
15.538 ml |
31.075 ml |
| 5 mM |
0.622 ml |
3.108 ml |
6.215 ml |
| 10 mM |
0.311 ml |
1.554 ml |
3.108 ml |
| 50 mM |
0.062 ml |
0.311 ml |
0.622 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |